Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available (further information necessary)

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

No data on the repeated dose toxicity of the substance are available yet. Therefore the registrant submits a testing proposal for a sub-chronic (90 days) toxicity study.


Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Taking into account that the tonnage band of 100 tonnes/year has been exceeded, the performance of a sub-chronic (90 days) toxicity study is required. Therefore, the registrant submits a testing proposal for a sub-chronic (90 days) toxicity study.

Justification for classification or non-classification

No data on the repeated dose toxicity of the substance are available yet. Classification or non-classification will be justified when data has become available.